FDA Webinar on Over-the-Counter Naloxone Nasal Spray

Good afternoon, Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription. Please see the press release regarding the announcement. Please note, you can and should continue to purchase and distribute naloxone products with grant funds and receive discounts through the 340B program. There will be a webinar hosted by the FDA to provide additional information, scheduled for Thursday, March 30, 2023, at 11:00 am ET. Click here to join the webinar Meeting ID: 161 639 3315 Passcode: A=gj0b HRSA will be communicating additional information over the coming weeks however, should you have any questions, please reach out to your HRSA contacts.      Sign up for eNews More HRSA email updates / Unsubscribe  |  Help  Health Resources and Services Administration 5600 Fishers Lane | Rockville, MD 20857 This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: HRSA · 5600 Fishers Lane · Rockville, MD 20857